We are live on
!
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $6.07M invested in Tonix Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
366% more capital invested
Capital invested by funds: $1.3M → $6.07M (+$4.77M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $104K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$104K
Net Calls
-$104K
Net Calls Change
-$99K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$46K |
| 2 |
RHBC
R.H. Bluestein & Co
Birmingham,
Michigan
|
-$36K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$34K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$16K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$10K |
